寧波中百(600857.SH)捐贈1000萬元用於抗擊肺炎疫情
格隆匯2月2日丨寧波中百(600857.SH)公佈,近日,新型冠狀病毒肺炎疫情席捲全國,公司和大股東西藏澤添投資發展有限公司高度關注疫情進展。為助力疫情防控,公司大股東西藏澤添提議:捐贈人民幣1,000萬元用於購買醫療物資及設備,支援寧波地區抗擊肺炎疫情。其中,捐贈給寧波市紅十字會和寧波市慈善總會各500萬元。本次捐贈事項已經公司第九屆董事會第十一次會議審議,獲全體董事一致同意通過。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.